Education Center

The Benefits and Risks of Oral Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Funding for this newsletter series was provided by AstraZeneca

 

The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.

The third eNewsletter, The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome, reviews the evidence on the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.

Click here to read the supplement

Recommended for You

Articles from The Journal of Family Practice

Quizzes from MD-IQ

Research Summaries from ClinicalEdge